Added to YB: 2024-06-25
Pitch date: 2024-06-25
EIGR [bullish]
Eiger BioPharmaceuticals, Inc.
-34.92%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
On September 30, 2024, Eiger BioPharmaceuticals, Inc. went out of business as per its Chapter 11 liquidation filing under bankruptcy.
Market Cap
$12.6M
Pitch Price
$13.06
Price Target
N/A
Dividend
N/A
EV/EBITDA
-0.39
P/E
-0.17
EV/Sales
1.77
Sector
Biotechnology
Category
N/A
Show full summary:
EIGER BIOPHARMACEUTICALS INC EIGR
A summary for this pitch has not been created yet.
Read full article (0 min)